Xanthine Oxidase Inhibitors for Improving Renal Function in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis.

Anna PisanoValeria CernaroGuido GembilloGraziella D'ArrigoMichele BuemiDavide Bolignano

Published in: International journal of molecular sciences (2017)

XOis may represent a promising tool for retarding disease progression in CKD patients. Future trials are awaited to confirm the generalizability of these findings to the whole CKD population.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
peritoneal dialysis
metabolic syndrome
patient reported